【摘要】 【关键词】 肺小细胞肺癌;综合治疗;放疗;化疗 chemotherapy combined with different dosage radiotherapy in treatment of local and advanced nonsmall cell lung cancer su binguang, zhang kunqiang, ling huahuang, cai maode,lin fuxing department of chemotherapy , gaozou people's hospital of guangdong province, gaozou 52500, china;department of radiotherapy abstract:objective to evaluate the technique, effect, prognosis and side effects of chemotherapy combined with low dosage radiotherapy for patients with local and advanced nonsmall cell lung cancer.methods from july 1989 to july 2001, a total 68 patients with pathologically confirmed nonsmall cell lung cancer were retrospectively analyzed. according to the different dosage radiotherapy, the patients were divided into treatment group(chemotherapy plus low dosage mdiotherapy) and control group(chemotherapy plus standarddosageradiotherapy). the chemotherapy regiment with cep (ctx,ddp, vp16) were used in two groups. the dosage of radiotherapy is 45gy in treatment group and 60~70gy in control group.results the 1,2,3 and 4year survival rates in treatment group and control group were 61%, 21.2%, 9.1%, 9.1% and 85.7%, 11.4%, 2.86%, 0% respectively. there was significant difference between two groups in 1year survival rate. there was not significant difference between two groups in 2,3,4year survival rates. there was significant difference between two groups in hemotologic toxicities and radiolung injury.conclusion chemotherapy combined with low dosage radiotherapy for patients with local and advanced nonsmall cell lung cancer could significantly improve quality of life with achieving equal the survival between two groups. key words:nonsmall cell lung cancer;combined modality therapy; radiotherapy; chemotherapy 0 引言 1 资料与方法 1.1 临床资料 1989年7月~2001年7月共有资料完整、经组织学或细胞学确诊、有可测量影像学指标、接受cep方案化疗联合放疗综合治疗的中晚期非小细胞肺癌患者68例。根据所接受放疗剂量不同将这些病例分成治疗组和对照组。治疗组(化疗+低剂量放疗)33例;对照组(化疗+根治性放疗)35例。治疗组男23例,女10例,年龄45~71岁,中位年龄53岁;对照组男25例,女10例,年龄47~75岁,中位年龄55岁。病理类型:治疗组鳞癌22例,腺癌11例;对照组鳞癌23例,腺癌12例。分期:按1997年肺癌uicc分期法进行分期,治疗组ⅱa期2例,ⅱb期4例,ⅲa期9例,ⅲb期10例,ⅳ期8例;对照组ⅱa期1例,ⅱb期5例,ⅲa期9例,ⅲb期11例,ⅳ期9例。治疗前患者活动状况按ecog计分,治疗组0~ⅱ级28例,ⅲ级5例;对照组0~ⅱ级31例,ⅲ级4例;治疗前1个月未作过任何抗肿瘤治疗,外周血、肝功能、心功能、肾功能等均正常。 1.2 治疗方法 1.2.1 化疗方案 1.2.2 放疗方法 2 结果 2.1 疗效 表1 不同剂量组放疗后的远处转移及放射性肺损伤(略) 表2 不同剂量组放疗后的生存时间(略) 2.2 毒副作用 按who的毒性评定标准分为0、ⅰ、ⅲ、ⅳ度。治疗组33例中出现骨髓抑制ⅰ~ⅱ度者28例,ⅲ度5例;胃肠道反应ⅰ、ⅱ度26例,ⅲ度7例;脱发ⅰ、ⅱ度22例,ⅲ度11例;放射性肺损伤2例。对照组骨髓抑制ⅰ~ⅱ度20例,ⅲ度15例;胃肠道反应ⅰ、ⅱ度27例,ⅲ度8例;脱发ⅰ~ⅱ度25例,ⅲ度10例;放射性肺损伤9例。两组病例治疗后均无肝、肾功能损害,但是对照组3例死于心肌损伤。表3的结果表明化疗加根治量放疗可明显增加骨髓抑制及放射性肺损伤的发生,两组比较差异存在显著性(p<0.05)。 表3 不同剂量组放疗后的毒副作用(略) 3 讨论 【参考文献 |
化疗联合不同剂量放疗治疗中晚期非小细胞肺癌简介:
【摘要】 目的 探讨化疗加低剂量放疗综合治疗中晚期非小细胞肺癌的方法、疗效、预后及其副反应。方法 回顾性分析68例经病理确诊为非小细胞肺癌患者资料,根据所接受的放疗剂量不同分成。治疗组(化 ... 责任编辑:admin
|
最新文章更多
推荐文章更多
热点文章更多 |